Cargando…
GBT440 Inhibits Sickling of Sickle Cell Trait Blood Under In Vitro Conditions Mimicking Strenuous Exercise
In sickle cell trait (SCT), hemoglobin A (HbA) and S (HbS) are co-expressed in each red blood cell (RBC). While homozygous expression of HbS (HbSS) leads to polymerization and sickling of RBCs resulting in sickle cell disease (SCD) characterized by hemolytic anemia, painful vaso-occlusive episodes a...
Autores principales: | Dufu, Kobina, Lehrer-Graiwer, Josh, Ramos, Eleanor, Oksenberg, Donna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062624/ https://www.ncbi.nlm.nih.gov/pubmed/27757216 http://dx.doi.org/10.4081/hr.2016.6637 |
Ejemplares similares
-
GBT440 reverses sickling of sickled red blood cells under hypoxic conditions in vitro
por: Dufu, Kobina, et al.
Publicado: (2018) -
Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell disease
por: Hutchaleelaha, Athiwat, et al.
Publicado: (2019) -
Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease
por: Telfer, Paul, et al.
Publicado: (2018) -
Discovery of GBT440,
an Orally Bioavailable R-State
Stabilizer of Sickle Cell Hemoglobin
por: Metcalf, Brian, et al.
Publicado: (2017) -
The effect of the antisickling compound GBT1118 on the permeability of red blood cells from patients with sickle cell anemia
por: Al Balushi, Halima, et al.
Publicado: (2019)